Endorphins and Central Neurotransmitters in Clinical Pain

  • L. Terenius


Present-day knowledge about the chemical transmitters involved in pain and pain modulation is immensely more advanced than only a few years ago. This knowledge extends into at least four different areas, the primary afferent system, the circuitry at the level of the first synapse in the dorsal horn of the spinal cord, supraspinal sites of pain modulation and finally the descending control systems. The problem we address ourselves is how this new knowledge can be applied to clinical pain, to generate disease models and to develop new treatment strategies.


Chronic Pain Pain Syndrome Trigeminal Neuralgia Clinical Pain Chronic Pain Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Almay, B. G. L., Johansson, F., von Knorring, L., Sedvall, G. & Terenius, L. (1980). Relationships between CSF levels of endorphins and monoamine metabolites in chronic pain patients. Psychopharmac., 67, 139–142.CrossRefGoogle Scholar
  2. Almay, B. G. L., Johansson, F., von Knorring, L., Terenius, L. & Äström, M. (1978). Endorphins in chronic pain. I. Differences in CSF endorphin levels between organic and psychogenic pain syndromes. Pain, 5, 153–162.CrossRefPubMedGoogle Scholar
  3. Åsberg, M., Thorén, P., Träskman, L., Bertilsson, L. & Ringberger, V. (1976). Serotonin depression — A biochemical subgroup within the affective disorders? Science, 191, 478–480.CrossRefPubMedGoogle Scholar
  4. Besson, J.-M. R. (1980). Supraspinal modulation of the segmental transmission of pain. In Pain and Society, ed. Kosterlitz, H. W. & Terenius, L., pp. 161–182. Weinheim: Verlag Chemie GmbH.Google Scholar
  5. Fields, H. L. & Basbaum, A. I. (1978). Brainstem control of spinal pain transmission neurons. Ann. Rev. Physiol., 40, 193–221.CrossRefGoogle Scholar
  6. Goodwin, F. K., Muscettola, J., Gold, P. W. & Wehr, F. (1978). Psychiatric diagnosis. New York: Spectrum Publications.Google Scholar
  7. Henry, J. L. (1976). Effects of substance P on functionally identified units in cat spinal cord. Brain Res., 114, 439–452.CrossRefPubMedGoogle Scholar
  8. Hökfelt, T., Ljungdahl, A., Terenius, L., Elde, R. & Nilsson, G. (1977). Immunohistochemical analysis of peptide pathways possibly related to pain and analgesia: Enkephalin and substance P. Proc. Nat. Acad. Sci. USA, 74, 3081–3085.PubMedCentralCrossRefPubMedGoogle Scholar
  9. Hosobuchi, Y., Adams, J. E. & Linchitz, R. (1977). Pain relief by electrical stimulation of central gray matter in humans, and its reversal by naloxone. Science, 197, 183–186.CrossRefPubMedGoogle Scholar
  10. Jessel, T. M. & Iversen, L. L. (1977). Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature, 268, 549–551.CrossRefGoogle Scholar
  11. Johansson, F. & von Knorring, L. (1979). A double-blind controlled study of a serotonin uptake inhibitor (zimelidine) versus placebo in chronic pain patients. Pain, 7, 69–78.CrossRefPubMedGoogle Scholar
  12. Johansson, F., von Knorring, L., Sedvall, G. & Terenius, L. (1980). Changes in endorphins and 5-hydroxyindoleacetic acid in cerebrospinal fluid as a result of treatment with a serotonin-reuptake inhibitor (zimelidine) in chronic pain patients. Psychiat. Res., 2, 167–172.CrossRefGoogle Scholar
  13. Lamotte, C., Pert, C. B. & Snyder, S. H. (1976). Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res., 112, 407–412.CrossRefPubMedGoogle Scholar
  14. Lascelles, P. T., Evans, P. R., Merskey, H. & Sabur, M. A. (1974). Plasma Cortisol in psychiatric and neurological patients with pain. Brain, 97, 533–538.CrossRefPubMedGoogle Scholar
  15. Levine, J. D., Gordon, N. C., Jones, R. T. & Fields, H. L. (1978). The narcotic antagonist naloxone enhances clinical pain. Nature, 272, 826–827.CrossRefPubMedGoogle Scholar
  16. Lombard, M. C., Nashold, B. S., Jr. & Albe-Fessard, D. (1979). Deafferentation hypersensitivity in the rat after dorsal rhizotomy. A possible animal model for chronic pain. Pain, 6, 163–168.CrossRefPubMedGoogle Scholar
  17. Merskey, H. & Hester, R. N. (1972). The treatment of chronic pain with psychotropic drugs. Postgrad. med. J., 48, 594–598.PubMedCentralCrossRefPubMedGoogle Scholar
  18. Ögren, S. O. & Holm, A.-C. (1980). Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia. J. Neural Transm., 47, 253–271.CrossRefPubMedGoogle Scholar
  19. Shenkin, H. A. (1964). The effect of pain on the diurnal pattern of plasma corticoid levels. Neurology, 14, 1112–1115.CrossRefPubMedGoogle Scholar
  20. Sjölund, B. H. & Eriksson, M. B. E. (1979). The influence of naloxone on analgesia produced by peripheral conditioning stimulation. Brain Res., 173, 295–301.CrossRefPubMedGoogle Scholar
  21. Sjölund, B. H., Terenius, L. & Eriksson, M. B. E. (1977). Increased cerebrospinal fluid levels of endorphins after electroacupuncture. Acta physiol. Scand., 100, 382–384.CrossRefPubMedGoogle Scholar
  22. Sternbach, R. A. (1974). Pain Patients: Traits and Treatment. New York: Academic Press.Google Scholar
  23. Sternbach, R. A. (1976). The need for an animal model of chronic pain. Pain, 2, 2–4.PubMedGoogle Scholar
  24. Tamsen, A., Hartvig, P., Dahlström, B., Wahlström, A. & Terenius, L. (1980). Endorphins and on-demand pain relief. Lancet, 1, 769–770.CrossRefPubMedGoogle Scholar
  25. Terenius, L. (1978). Endogenous peptides and analgesia. Ann. Rev. Pharmac. Toxicol., 18, 189–204.CrossRefGoogle Scholar
  26. Terenius, L. & Wahlström, A. (1975). Morphine-like ligand for opiate receptors in human CSF. Life Sci., 16, 1759–1764.CrossRefGoogle Scholar
  27. Terenius, L. & Wahlström, A. (1979). Endorphins and clinical pain, an overview. Adv. exp. Med. Biol., 116, 261–277.CrossRefPubMedGoogle Scholar
  28. Terenius, L., Wahlström, A. & Ågren, H. (1977). Naloxone treatment in depression: Clinical observations and effects on CSF endorphins and monoamine metabolites. Psychopharmac., 54, 31–33.CrossRefGoogle Scholar
  29. von Knorring, L. (1975). The experience of pain in patients with depressive disorders. A clinical and experimental study. Umeå University Medical Dissertations, New Series, 2.Google Scholar
  30. von Knorring, L., Almay, B. G. L., Johansson, F. & Terenius, L. (1978). Pain perception and endorphin levels in cerebrospinal fluid. Pain, 5, 359–365.CrossRefGoogle Scholar
  31. von Knorring, L., Almay, B. G. L., Johansson, F. & Terenius, L. (1979). Endorphins in CSF of chronic pain patients, in relation to augmenting-reducing response in visual averaged evoked response. Neuropsychobiol., 5, 322–326.CrossRefGoogle Scholar
  32. Wahlström, A. & Terenius, L. (1980). Chemical characteristics of endorphins in human cerebrospinal fluid. FEBS Letter, in press.Google Scholar
  33. Wall, P. D., Scadding, J. W. & Tomkiewicz, M. M. (1979). The production and prevention of experimental anaesthesia dolorosa. Pain, 6, 175–182.CrossRefPubMedGoogle Scholar
  34. Woods, J. H. (1980). Neurochemical analysis of cerebrospinal fluid. Neurology, 30, 645–651.CrossRefGoogle Scholar

Copyright information

© The contributors 1980

Authors and Affiliations

  • L. Terenius
    • 1
  1. 1.Department of PharmacologyUniversity of UppsalaSweden

Personalised recommendations